{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:32:10Z","timestamp":1789590730315,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","award":["70114733"],"award-info":[{"award-number":["70114733"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.euros.2025.12.018","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:58:49Z","timestamp":1767790729000},"page":"13-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer\u2014Introducing the Prospective \u201cProFam-Risk\u201d Study"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2368-8788","authenticated-orcid":false,"given":"Jale","family":"Lakes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Boschheidgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Antoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike K.","family":"Klett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Karger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Redler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangalore G.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja N.","family":"Fehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Niegisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman T.","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Albers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2025.12.018_b0005","unstructured":"Zentrum f\u00fcr Krebsregisterdaten. Prostatakrebs (Prostatakarzinom). https:\/\/www.krebsdaten.de\/Krebs\/DE\/Content\/Krebsarten\/Prostatakrebs\/prostatakrebs_node.html."},{"key":"10.1016\/j.euros.2025.12.018_b0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030361","article-title":"The epidemiology of prostate cancer","volume":"8","author":"Pernar","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.euros.2025.12.018_b0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial risk and heritability of cancer among twins in Nordic countries","volume":"315","author":"Mucci","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.euros.2025.12.018_b0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/annonc\/mdr056","article-title":"Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer","volume":"23","author":"Brandt","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euros.2025.12.018_b0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2010.02.002","article-title":"Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members","volume":"58","author":"Brandt","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.018_b0030","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.urology.2006.06.028","article-title":"Association between family history of prostate and breast cancer among African-American men with prostate cancer","volume":"68","author":"Beebe-Dimmer","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.euros.2025.12.018_b0035","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/cncr.29075","article-title":"Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study","volume":"121","author":"Beebe-Dimmer","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.euros.2025.12.018_b0040","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1200\/JCO.19.02808","article-title":"Risk of prostate cancer associated with familial and hereditary cancer syndromes","volume":"38","author":"Beebe-Dimmer","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2025.12.018_b0045","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.3390\/cancers13174385","article-title":"Familial risks and proportions describing population landscape of familial cancer","volume":"13","author":"Hemminki","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.euros.2025.12.018_b0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamaoncol.2018.6760","article-title":"Prevalence of germline variants in prostate cancer and implications for current genetic testing guidelines","volume":"5","author":"Nicolosi","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euros.2025.12.018_b0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJMoa1110000","article-title":"Germline mutations in HOXB13 and prostate-cancer risk","volume":"366","author":"Ewing","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2025.12.018_b0060","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.21.02112","article-title":"Cancer risks associated with BRCA1 and BRCA2 pathogenic variants","volume":"40","author":"Li","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2025.12.018_b0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1086\/346094","article-title":"Mutations in CHEK2 associated with prostate cancer risk","volume":"72","author":"Dong","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.euros.2025.12.018_b0070","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.bjc.6602007","article-title":"ATM polymorphisms as risk factors for prostate cancer development","volume":"91","author":"Angele","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euros.2025.12.018_b0075","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2021.10.036","article-title":"Inherited TP53 variants and risk of prostate cancer","volume":"81","author":"Maxwell","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.018_b0080","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/jamaoncol.2023.3482","article-title":"Germline sequencing analysis to inform clinical gene panel testing for aggressive prostate cancer","volume":"9","author":"Darst","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euros.2025.12.018_b0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10689-014-9744-1","article-title":"High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry","volume":"13","author":"Rosty","year":"2014","journal-title":"Fam Cancer"},{"key":"10.1016\/j.euros.2025.12.018_b0090","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.2012.43.1882","article-title":"Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer","volume":"31","author":"Castro","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2025.12.018_b0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.eururo.2014.10.022","article-title":"Effect of BRCA mutations on metastatic relapse and cause-specific survival after radical treatment for localised prostate cancer","volume":"68","author":"Castro","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.018_b0100","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.eururo.2018.09.021","article-title":"Germline mutations in ATM and BRCA1\/2 are associated with grade reclassification in men on active surveillance for prostate cancer","volume":"75","author":"Carter","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.018_b0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0959-8049(99)00272-5","article-title":"Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer","volume":"36","author":"Bratt","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euros.2025.12.018_b0110","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/bju.14412","article-title":"Psychosocial impact of undergoing prostate cancer screening for men with BRCA 1 or BRCA 2 mutations","volume":"123","author":"Bancroft","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2025.12.018_b0115","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.20.00046","article-title":"Implementation of germline testing for prostate cancer: Philadelphia Prostate Cancer Consensus Conference 2019","volume":"38","author":"Giri","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2025.12.018_b0120","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.euros.2025.12.018_b0125","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.eururo.2020.01.012","article-title":"Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019","volume":"77","author":"Gillessen","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.018_b0130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.eururo.2019.08.019","article-title":"Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers","volume":"76","author":"Page","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.018_b0135","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.euo.2024.01.015","article-title":"Magnetic resonance imaging\u2013based prostate cancer screening in carriers of pathogenic germline mutations: interim results from the initial screening round of the prostate cancer genetic risk evaluation and screening study","volume":"7","author":"Amini","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2025.12.018_b0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-103679","article-title":"Psychosocial outcomes of risk-adapted prevention for prostate cancer predisposition: study protocol for a longitudinal observational mixed-methods study","volume":"15","author":"Klett","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.euros.2025.12.018_b0145","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.018_b0150","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.eururo.2013.05.022","article-title":"Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial","volume":"64","author":"Arsov","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.018_b0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f2023","article-title":"Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study","volume":"346","author":"Vickers","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.euros.2025.12.018_b0160","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.eururo.2011.11.012","article-title":"Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators","volume":"61","author":"Roobol","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.018_b0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.eururo.2023.09.027","article-title":"Multiparametric magnetic resonance imaging in prostate cancer screening at the age of 45 years: results from the first screening round of the PROBASE trial","volume":"85","author":"Boschheidgen","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.12.018_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2023.111151","article-title":"Multiparametric MRI characteristics of prostatitis and atrophy in the peripheral zone in men without prostate cancer","volume":"169","author":"Al-Monajjed","year":"2023","journal-title":"Eur J Radiol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168325024978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168325024978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:05:05Z","timestamp":1771866305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168325024978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"alternative-id":["S2666168325024978"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2025.12.018","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer\u2014Introducing the Prospective \u201cProFam-Risk\u201d Study","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2025.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}